Status:
ACTIVE_NOT_RECRUITING
Characteristics of Long COVID-19 Syndrome
Lead Sponsor:
Christian Clarenbach
Conditions:
Long COVID Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Characterization of patients with long COVID syndrome including symptoms, medical history and persistent organ damage.
Detailed Description
Some people are very hesitant to recover from a COVID-19 infection and present persistent symptoms. The participants still suffer after the acute phase of the infection from shortness of breath, cough...
Eligibility Criteria
Inclusion
- Long COVID syndrome
- age \>= 18 years
- Informed consent
Exclusion
- none
Key Trial Info
Start Date :
February 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04793269
Start Date
February 23 2021
End Date
December 31 2025
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8091